Diabetes Management & Remission
Structured de-escalation of glycaemic load with the goal of sustained remission where clinically achievable.
We integrate modern medical science with Ayurvedic root-cause healing — precision diagnostics, continuous glucose intelligence and personalised therapy designed around your metabolic subtype, not an average patient.
Integrative Diabetes Center
Integrative Diabetes Center
One clinical pathway, four destinations. Wherever you are on the metabolic spectrum, the protocol adapts to you.
Structured de-escalation of glycaemic load with the goal of sustained remission where clinically achievable.
Protecting nerves, kidneys, retina and vasculature — the outcomes that actually determine quality of life.
The highest-leverage window. Intervene before beta-cell reserve declines and reverse the trajectory entirely.
Visceral fat, insulin resistance, dyslipidaemia and fatty liver treated as one connected system.
Conventional single-track diabetes treatment faces structural limitations. It's time to embrace a personalised, root-cause approach.
Conventional oral hypoglycaemic drugs progressively lose efficacy after roughly 5 years, driving dose escalation and eventual insulin dependence.
Treating 5+ distinct diabetes subtypes with a single common protocol predictably produces poor outcomes for most patients.
Glucose management alone fails to address the micro- and macrovascular complications that drive real morbidity.
Inflammation, gut dysbiosis, chronic stress and sleep debt are rarely measured — yet they are upstream of the glucose number.
Manage or reverse diabetes and its complications effectively — by treating the person, the pathway and the pathology together.
Blending ancient wisdom with modern clinical precision to identify your unique metabolic health profile before a single therapy is prescribed.
Structured assessment of constitution, agni (digestive fire), srotas and dosha imbalance — mapped to modern metabolic phenotypes.
Continuous glucose monitoring reveals your true glycaemic variability, dawn phenomenon, meal responses and time-in-range — not a single fasting number.
HbA1c, fasting insulin, HOMA-IR, hs-CRP, lipid subfractions, thyroid, vitamin D, renal and hepatic panels — plus gut microbiome sequencing.
Photograph your plate. Our AI estimates glycaemic load and correlates it against your live CGM curve — so you learn which foods your body reacts to.
Your data is reviewed together by an Ayurveda expert and a diabetologist — one shared plan, no contradictory advice.
Modern cluster analysis identifies at least five distinct Type-2 diabetes subtypes. Ayurveda has classified metabolic constitution for two millennia. We map one onto the other — and treat what you actually have.
Five levers, sequenced and dosed to your subtype. Modern medicine stabilises fast; the rest builds durability.
Evidence-based pharmacotherapy to stabilise glycaemia — then systematically tapered as markers improve.
Short termStandardised, quality-controlled Ayurvedic formulations selected for your dosha and biomarker profile.
Core protocolMeal plans built from your own CGM responses — not generic charts. Indian-kitchen realistic.
DailyPost-prandial protocols and resistance work prescribed for insulin sensitivity, not calorie burn.
5×/weekCortisol and circadian repair — the most under-treated driver of morning hyperglycaemia.
NightlyAggregate data from participants in the Ayur.AI integrative program, measured at baseline and at two months.
Indicates reduced insulin demand and meaningfully improved insulin sensitivity.
Better baseline glucose control across the full 24-hour cycle, not just at the clinic.
Reduced systemic inflammation — better insulin sensitivity and lower long-term complication risk.
Figures represent aggregate outcomes observed among Ayur.AI program participants and are shared for information only. Individual results vary with adherence, baseline severity, duration of diabetes and comorbidities. This program complements — and does not replace — the care of your treating physician.
A defined clinical pathway with measurable checkpoints — so you always know where you are and what's next.
Full blood panel, Ayurvedic assessment, CGM applied, AIWELL app set up. Your true starting point, documented.
Your subtype is confirmed. Diet, herbs, movement and medication are calibrated against live glucose data.
Repeat biomarkers at 8 weeks. Where markers permit, medication is stepped down under supervision.
Transition to a maintenance protocol with quarterly review and ongoing complication screening.
The program is designed for specific clinical situations. Here's an honest view of where it works best — and where it doesn't.
Diagnosed within the last 8 years, with retained beta-cell function. This is the highest-yield group for remission.
HbA1c stuck or creeping upward despite adherence, or facing escalation to a third agent or insulin.
Central obesity, fatty liver, PCOS, dyslipidaemia or hypertension alongside raised glucose.
Emerging neuropathy, microalbuminuria or retinopathy where slowing progression is the priority.
Not yet diabetic but genetically loaded — prevention with objective tracking rather than annual guessing.
Type 1 diabetes, pregnancy, advanced renal failure or acute decompensation are referred to appropriate specialist care first.
Integrative care fails when practitioners work in parallel. At Ayur.AI, every plan is jointly authored and jointly reviewed.
Owns pharmacotherapy, safety thresholds, complication screening and the medication taper schedule. Every de-escalation is medically supervised.
Owns constitutional assessment, herbal formulation, agni and srotas correction, and lifestyle prescription aligned to your dosha.
Your single point of contact. Reviews CGM data weekly, troubleshoots real life, and keeps both clinicians synchronised on your progress.
Book a consultation with our integrative care team — or partner with Ayur.AI to scale the first of its kind Integrative Diabetes Clinics in your city.
Tell us about yourself to get started.
No — and you should never stop on your own. You continue your existing prescription while we gather baseline data. Any reduction is made by our diabetologist, gradually, and only when your biomarkers and CGM data support it safely.
No. Clinically we aim for remission — normal glucose markers sustained without glucose-lowering medication. The underlying predisposition remains, so remission must be maintained through continued lifestyle and periodic monitoring. We are deliberately precise about this distinction.
A continuous glucose monitor is a small coin-sized sensor worn on the upper arm with a filament thinner than a hair. Application takes seconds and is close to painless. It streams glucose readings to your phone continuously for up to 14 days — no finger pricks.
We use standardised, quality-controlled formulations and screen every plan for herb–drug interactions with your diabetologist before it is issued. Renal and hepatic function are monitored during the program. Tell us about every medicine and supplement you take, including over-the-counter ones.
The baseline assessment is best done in person at our Chennai centre. After that, most of the program runs through the AIWELL app with scheduled teleconsultations, so patients across India and abroad can participate. Lab work can be arranged locally.
Most participants see visibly flatter post-meal glucose curves within the first two weeks. Structural markers like fasting insulin and hs-CRP typically shift meaningfully by the eight-week repeat panel. HbA1c, being a 90-day average, is reassessed at three months.
The remission pathway is designed for Type 2 diabetes and pre-diabetes. People with Type 1 require lifelong insulin and are managed by their endocrinologist; we can support adjunctive lifestyle and complication-prevention care only, in coordination with that specialist.